0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oseltamivir Phosphate Antiviral Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-22P13682
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Oseltamivir Phosphate Antiviral Drug Market Research Report 2023
BUY CHAPTERS

Global Oseltamivir Phosphate Antiviral Drug Market Research Report 2025

Code: QYRE-Auto-22P13682
Report
May 2025
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oseltamivir Phosphate Antiviral Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Oseltamivir Phosphate Antiviral Drug Market

Oseltamivir Phosphate Antiviral Drug Market

The global market for Oseltamivir Phosphate Antiviral Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Tamiflu (oseltamivir phosphate) is an oral anti-viral drug approved for the treatment of acute, uncomplicated influenza in patients 2 weeks of age and older whose flu symptoms have not lasted more than two days
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oseltamivir Phosphate Antiviral Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oseltamivir Phosphate Antiviral Drug.
The Oseltamivir Phosphate Antiviral Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oseltamivir Phosphate Antiviral Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oseltamivir Phosphate Antiviral Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oseltamivir Phosphate Antiviral Drug Market Report

Report Metric Details
Report Name Oseltamivir Phosphate Antiviral Drug Market
CAGR 5%
Segment by Type
  • Capsule
  • Suspension
Segment by Application
  • Child
  • Aldult
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche Group, Alvogen, Teva Pharmaceuticals, Camber Pharmaceuticals, LUPINE Limited, Amneal Pharmaceuticals, Novadoz, Natco Pharma, Strides Pharma Inc., Zydus Cadila, Alembic Pharmaceuticals, Hetero Group, Macleods Pharmaceuticals, Ajanta Pharma, HEC ChangJiang Pharmaceutical, SL Pharmaceutica, BrightGene Bio-Medical Technology, Kelun Pharmaceutical, Cspc Holdings
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oseltamivir Phosphate Antiviral Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Oseltamivir Phosphate Antiviral Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Oseltamivir Phosphate Antiviral Drug Market report?

Ans: The main players in the Oseltamivir Phosphate Antiviral Drug Market are Roche Group, Alvogen, Teva Pharmaceuticals, Camber Pharmaceuticals, LUPINE Limited, Amneal Pharmaceuticals, Novadoz, Natco Pharma, Strides Pharma Inc., Zydus Cadila, Alembic Pharmaceuticals, Hetero Group, Macleods Pharmaceuticals, Ajanta Pharma, HEC ChangJiang Pharmaceutical, SL Pharmaceutica, BrightGene Bio-Medical Technology, Kelun Pharmaceutical, Cspc Holdings

What are the Application segmentation covered in the Oseltamivir Phosphate Antiviral Drug Market report?

Ans: The Applications covered in the Oseltamivir Phosphate Antiviral Drug Market report are Child, Aldult

What are the Type segmentation covered in the Oseltamivir Phosphate Antiviral Drug Market report?

Ans: The Types covered in the Oseltamivir Phosphate Antiviral Drug Market report are Capsule, Suspension

Recommended Reports

Antiviral Drug Markets

Influenza Related Markets

API and Drug Substance

1 Oseltamivir Phosphate Antiviral Drug Market Overview
1.1 Product Definition
1.2 Oseltamivir Phosphate Antiviral Drug by Type
1.2.1 Global Oseltamivir Phosphate Antiviral Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Capsule
1.2.3 Suspension
1.3 Oseltamivir Phosphate Antiviral Drug by Application
1.3.1 Global Oseltamivir Phosphate Antiviral Drug Market Value by Application (2024 VS 2031)
1.3.2 Child
1.3.3 Aldult
1.4 Global Oseltamivir Phosphate Antiviral Drug Market Size Estimates and Forecasts
1.4.1 Global Oseltamivir Phosphate Antiviral Drug Revenue 2020-2031
1.4.2 Global Oseltamivir Phosphate Antiviral Drug Sales 2020-2031
1.4.3 Global Oseltamivir Phosphate Antiviral Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Oseltamivir Phosphate Antiviral Drug Market Competition by Manufacturers
2.1 Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Oseltamivir Phosphate Antiviral Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Oseltamivir Phosphate Antiviral Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oseltamivir Phosphate Antiviral Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oseltamivir Phosphate Antiviral Drug, Product Type & Application
2.7 Global Key Manufacturers of Oseltamivir Phosphate Antiviral Drug, Date of Enter into This Industry
2.8 Global Oseltamivir Phosphate Antiviral Drug Market Competitive Situation and Trends
2.8.1 Global Oseltamivir Phosphate Antiviral Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oseltamivir Phosphate Antiviral Drug Players Market Share by Revenue
2.8.3 Global Oseltamivir Phosphate Antiviral Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oseltamivir Phosphate Antiviral Drug Market Scenario by Region
3.1 Global Oseltamivir Phosphate Antiviral Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Region: 2020-2031
3.2.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Region: 2020-2025
3.2.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Region: 2026-2031
3.3 Global Oseltamivir Phosphate Antiviral Drug Revenue by Region: 2020-2031
3.3.1 Global Oseltamivir Phosphate Antiviral Drug Revenue by Region: 2020-2025
3.3.2 Global Oseltamivir Phosphate Antiviral Drug Revenue by Region: 2026-2031
3.4 North America Oseltamivir Phosphate Antiviral Drug Market Facts & Figures by Country
3.4.1 North America Oseltamivir Phosphate Antiviral Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Oseltamivir Phosphate Antiviral Drug Sales by Country (2020-2031)
3.4.3 North America Oseltamivir Phosphate Antiviral Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oseltamivir Phosphate Antiviral Drug Market Facts & Figures by Country
3.5.1 Europe Oseltamivir Phosphate Antiviral Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Oseltamivir Phosphate Antiviral Drug Sales by Country (2020-2031)
3.5.3 Europe Oseltamivir Phosphate Antiviral Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oseltamivir Phosphate Antiviral Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Oseltamivir Phosphate Antiviral Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Oseltamivir Phosphate Antiviral Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Oseltamivir Phosphate Antiviral Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oseltamivir Phosphate Antiviral Drug Market Facts & Figures by Country
3.7.1 Latin America Oseltamivir Phosphate Antiviral Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Oseltamivir Phosphate Antiviral Drug Sales by Country (2020-2031)
3.7.3 Latin America Oseltamivir Phosphate Antiviral Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oseltamivir Phosphate Antiviral Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Oseltamivir Phosphate Antiviral Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Oseltamivir Phosphate Antiviral Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2020-2031)
4.1.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2020-2025)
4.1.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2026-2031)
4.1.3 Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Type (2020-2031)
4.2 Global Oseltamivir Phosphate Antiviral Drug Revenue by Type (2020-2031)
4.2.1 Global Oseltamivir Phosphate Antiviral Drug Revenue by Type (2020-2025)
4.2.2 Global Oseltamivir Phosphate Antiviral Drug Revenue by Type (2026-2031)
4.2.3 Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Type (2020-2031)
4.3 Global Oseltamivir Phosphate Antiviral Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2020-2031)
5.1.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2020-2025)
5.1.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2026-2031)
5.1.3 Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Application (2020-2031)
5.2 Global Oseltamivir Phosphate Antiviral Drug Revenue by Application (2020-2031)
5.2.1 Global Oseltamivir Phosphate Antiviral Drug Revenue by Application (2020-2025)
5.2.2 Global Oseltamivir Phosphate Antiviral Drug Revenue by Application (2026-2031)
5.2.3 Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Application (2020-2031)
5.3 Global Oseltamivir Phosphate Antiviral Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche Group
6.1.1 Roche Group Company Information
6.1.2 Roche Group Description and Business Overview
6.1.3 Roche Group Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Group Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.1.5 Roche Group Recent Developments/Updates
6.2 Alvogen
6.2.1 Alvogen Company Information
6.2.2 Alvogen Description and Business Overview
6.2.3 Alvogen Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Alvogen Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.2.5 Alvogen Recent Developments/Updates
6.3 Teva Pharmaceuticals
6.3.1 Teva Pharmaceuticals Company Information
6.3.2 Teva Pharmaceuticals Description and Business Overview
6.3.3 Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.3.5 Teva Pharmaceuticals Recent Developments/Updates
6.4 Camber Pharmaceuticals
6.4.1 Camber Pharmaceuticals Company Information
6.4.2 Camber Pharmaceuticals Description and Business Overview
6.4.3 Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.4.5 Camber Pharmaceuticals Recent Developments/Updates
6.5 LUPINE Limited
6.5.1 LUPINE Limited Company Information
6.5.2 LUPINE Limited Description and Business Overview
6.5.3 LUPINE Limited Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 LUPINE Limited Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.5.5 LUPINE Limited Recent Developments/Updates
6.6 Amneal Pharmaceuticals
6.6.1 Amneal Pharmaceuticals Company Information
6.6.2 Amneal Pharmaceuticals Description and Business Overview
6.6.3 Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.6.5 Amneal Pharmaceuticals Recent Developments/Updates
6.7 Novadoz
6.7.1 Novadoz Company Information
6.7.2 Novadoz Description and Business Overview
6.7.3 Novadoz Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Novadoz Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.7.5 Novadoz Recent Developments/Updates
6.8 Natco Pharma
6.8.1 Natco Pharma Company Information
6.8.2 Natco Pharma Description and Business Overview
6.8.3 Natco Pharma Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Natco Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.8.5 Natco Pharma Recent Developments/Updates
6.9 Strides Pharma Inc.
6.9.1 Strides Pharma Inc. Company Information
6.9.2 Strides Pharma Inc. Description and Business Overview
6.9.3 Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.9.5 Strides Pharma Inc. Recent Developments/Updates
6.10 Zydus Cadila
6.10.1 Zydus Cadila Company Information
6.10.2 Zydus Cadila Description and Business Overview
6.10.3 Zydus Cadila Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Zydus Cadila Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.10.5 Zydus Cadila Recent Developments/Updates
6.11 Alembic Pharmaceuticals
6.11.1 Alembic Pharmaceuticals Company Information
6.11.2 Alembic Pharmaceuticals Description and Business Overview
6.11.3 Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.11.5 Alembic Pharmaceuticals Recent Developments/Updates
6.12 Hetero Group
6.12.1 Hetero Group Company Information
6.12.2 Hetero Group Description and Business Overview
6.12.3 Hetero Group Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Hetero Group Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.12.5 Hetero Group Recent Developments/Updates
6.13 Macleods Pharmaceuticals
6.13.1 Macleods Pharmaceuticals Company Information
6.13.2 Macleods Pharmaceuticals Description and Business Overview
6.13.3 Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.13.5 Macleods Pharmaceuticals Recent Developments/Updates
6.14 Ajanta Pharma
6.14.1 Ajanta Pharma Company Information
6.14.2 Ajanta Pharma Description and Business Overview
6.14.3 Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.14.5 Ajanta Pharma Recent Developments/Updates
6.15 HEC ChangJiang Pharmaceutical
6.15.1 HEC ChangJiang Pharmaceutical Company Information
6.15.2 HEC ChangJiang Pharmaceutical Description and Business Overview
6.15.3 HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.15.4 HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.15.5 HEC ChangJiang Pharmaceutical Recent Developments/Updates
6.16 SL Pharmaceutica
6.16.1 SL Pharmaceutica Company Information
6.16.2 SL Pharmaceutica Description and Business Overview
6.16.3 SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.16.4 SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.16.5 SL Pharmaceutica Recent Developments/Updates
6.17 BrightGene Bio-Medical Technology
6.17.1 BrightGene Bio-Medical Technology Company Information
6.17.2 BrightGene Bio-Medical Technology Description and Business Overview
6.17.3 BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.17.4 BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.17.5 BrightGene Bio-Medical Technology Recent Developments/Updates
6.18 Kelun Pharmaceutical
6.18.1 Kelun Pharmaceutical Company Information
6.18.2 Kelun Pharmaceutical Description and Business Overview
6.18.3 Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.18.5 Kelun Pharmaceutical Recent Developments/Updates
6.19 Cspc Holdings
6.19.1 Cspc Holdings Company Information
6.19.2 Cspc Holdings Description and Business Overview
6.19.3 Cspc Holdings Oseltamivir Phosphate Antiviral Drug Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Cspc Holdings Oseltamivir Phosphate Antiviral Drug Product Portfolio
6.19.5 Cspc Holdings Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oseltamivir Phosphate Antiviral Drug Industry Chain Analysis
7.2 Oseltamivir Phosphate Antiviral Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oseltamivir Phosphate Antiviral Drug Production Mode & Process Analysis
7.4 Oseltamivir Phosphate Antiviral Drug Sales and Marketing
7.4.1 Oseltamivir Phosphate Antiviral Drug Sales Channels
7.4.2 Oseltamivir Phosphate Antiviral Drug Distributors
7.5 Oseltamivir Phosphate Antiviral Drug Customer Analysis
8 Oseltamivir Phosphate Antiviral Drug Market Dynamics
8.1 Oseltamivir Phosphate Antiviral Drug Industry Trends
8.2 Oseltamivir Phosphate Antiviral Drug Market Drivers
8.3 Oseltamivir Phosphate Antiviral Drug Market Challenges
8.4 Oseltamivir Phosphate Antiviral Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Oseltamivir Phosphate Antiviral Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Oseltamivir Phosphate Antiviral Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Oseltamivir Phosphate Antiviral Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Oseltamivir Phosphate Antiviral Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Oseltamivir Phosphate Antiviral Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Oseltamivir Phosphate Antiviral Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Oseltamivir Phosphate Antiviral Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Oseltamivir Phosphate Antiviral Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oseltamivir Phosphate Antiviral Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oseltamivir Phosphate Antiviral Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Oseltamivir Phosphate Antiviral Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oseltamivir Phosphate Antiviral Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oseltamivir Phosphate Antiviral Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oseltamivir Phosphate Antiviral Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Oseltamivir Phosphate Antiviral Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Oseltamivir Phosphate Antiviral Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Oseltamivir Phosphate Antiviral Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Oseltamivir Phosphate Antiviral Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Oseltamivir Phosphate Antiviral Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Oseltamivir Phosphate Antiviral Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Oseltamivir Phosphate Antiviral Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Oseltamivir Phosphate Antiviral Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Oseltamivir Phosphate Antiviral Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Oseltamivir Phosphate Antiviral Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Oseltamivir Phosphate Antiviral Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Oseltamivir Phosphate Antiviral Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Oseltamivir Phosphate Antiviral Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Oseltamivir Phosphate Antiviral Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Oseltamivir Phosphate Antiviral Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Oseltamivir Phosphate Antiviral Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Oseltamivir Phosphate Antiviral Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Oseltamivir Phosphate Antiviral Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Oseltamivir Phosphate Antiviral Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Oseltamivir Phosphate Antiviral Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Oseltamivir Phosphate Antiviral Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Oseltamivir Phosphate Antiviral Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Oseltamivir Phosphate Antiviral Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Oseltamivir Phosphate Antiviral Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Oseltamivir Phosphate Antiviral Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Oseltamivir Phosphate Antiviral Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Oseltamivir Phosphate Antiviral Drug Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Oseltamivir Phosphate Antiviral Drug Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Oseltamivir Phosphate Antiviral Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Oseltamivir Phosphate Antiviral Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Oseltamivir Phosphate Antiviral Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Oseltamivir Phosphate Antiviral Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Oseltamivir Phosphate Antiviral Drug Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Oseltamivir Phosphate Antiviral Drug Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Group Company Information
 Table 71. Roche Group Description and Business Overview
 Table 72. Roche Group Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Group Oseltamivir Phosphate Antiviral Drug Product
 Table 74. Roche Group Recent Developments/Updates
 Table 75. Alvogen Company Information
 Table 76. Alvogen Description and Business Overview
 Table 77. Alvogen Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Alvogen Oseltamivir Phosphate Antiviral Drug Product
 Table 79. Alvogen Recent Developments/Updates
 Table 80. Teva Pharmaceuticals Company Information
 Table 81. Teva Pharmaceuticals Description and Business Overview
 Table 82. Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product
 Table 84. Teva Pharmaceuticals Recent Developments/Updates
 Table 85. Camber Pharmaceuticals Company Information
 Table 86. Camber Pharmaceuticals Description and Business Overview
 Table 87. Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product
 Table 89. Camber Pharmaceuticals Recent Developments/Updates
 Table 90. LUPINE Limited Company Information
 Table 91. LUPINE Limited Description and Business Overview
 Table 92. LUPINE Limited Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. LUPINE Limited Oseltamivir Phosphate Antiviral Drug Product
 Table 94. LUPINE Limited Recent Developments/Updates
 Table 95. Amneal Pharmaceuticals Company Information
 Table 96. Amneal Pharmaceuticals Description and Business Overview
 Table 97. Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product
 Table 99. Amneal Pharmaceuticals Recent Developments/Updates
 Table 100. Novadoz Company Information
 Table 101. Novadoz Description and Business Overview
 Table 102. Novadoz Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Novadoz Oseltamivir Phosphate Antiviral Drug Product
 Table 104. Novadoz Recent Developments/Updates
 Table 105. Natco Pharma Company Information
 Table 106. Natco Pharma Description and Business Overview
 Table 107. Natco Pharma Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Natco Pharma Oseltamivir Phosphate Antiviral Drug Product
 Table 109. Natco Pharma Recent Developments/Updates
 Table 110. Strides Pharma Inc. Company Information
 Table 111. Strides Pharma Inc. Description and Business Overview
 Table 112. Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Product
 Table 114. Strides Pharma Inc. Recent Developments/Updates
 Table 115. Zydus Cadila Company Information
 Table 116. Zydus Cadila Description and Business Overview
 Table 117. Zydus Cadila Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Zydus Cadila Oseltamivir Phosphate Antiviral Drug Product
 Table 119. Zydus Cadila Recent Developments/Updates
 Table 120. Alembic Pharmaceuticals Company Information
 Table 121. Alembic Pharmaceuticals Description and Business Overview
 Table 122. Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product
 Table 124. Alembic Pharmaceuticals Recent Developments/Updates
 Table 125. Hetero Group Company Information
 Table 126. Hetero Group Description and Business Overview
 Table 127. Hetero Group Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Hetero Group Oseltamivir Phosphate Antiviral Drug Product
 Table 129. Hetero Group Recent Developments/Updates
 Table 130. Macleods Pharmaceuticals Company Information
 Table 131. Macleods Pharmaceuticals Description and Business Overview
 Table 132. Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product
 Table 134. Macleods Pharmaceuticals Recent Developments/Updates
 Table 135. Ajanta Pharma Company Information
 Table 136. Ajanta Pharma Description and Business Overview
 Table 137. Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Product
 Table 139. Ajanta Pharma Recent Developments/Updates
 Table 140. HEC ChangJiang Pharmaceutical Company Information
 Table 141. HEC ChangJiang Pharmaceutical Description and Business Overview
 Table 142. HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product
 Table 144. HEC ChangJiang Pharmaceutical Recent Developments/Updates
 Table 145. SL Pharmaceutica Company Information
 Table 146. SL Pharmaceutica Description and Business Overview
 Table 147. SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Product
 Table 149. SL Pharmaceutica Recent Developments/Updates
 Table 150. BrightGene Bio-Medical Technology Company Information
 Table 151. BrightGene Bio-Medical Technology Description and Business Overview
 Table 152. BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Product
 Table 154. BrightGene Bio-Medical Technology Recent Developments/Updates
 Table 155. Kelun Pharmaceutical Company Information
 Table 156. Kelun Pharmaceutical Description and Business Overview
 Table 157. Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product
 Table 159. Kelun Pharmaceutical Recent Developments/Updates
 Table 160. Cspc Holdings Company Information
 Table 161. Cspc Holdings Description and Business Overview
 Table 162. Cspc Holdings Oseltamivir Phosphate Antiviral Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Cspc Holdings Oseltamivir Phosphate Antiviral Drug Product
 Table 164. Cspc Holdings Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Oseltamivir Phosphate Antiviral Drug Distributors List
 Table 168. Oseltamivir Phosphate Antiviral Drug Customers List
 Table 169. Oseltamivir Phosphate Antiviral Drug Market Trends
 Table 170. Oseltamivir Phosphate Antiviral Drug Market Drivers
 Table 171. Oseltamivir Phosphate Antiviral Drug Market Challenges
 Table 172. Oseltamivir Phosphate Antiviral Drug Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oseltamivir Phosphate Antiviral Drug
 Figure 2. Global Oseltamivir Phosphate Antiviral Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oseltamivir Phosphate Antiviral Drug Market Share by Type: 2024 & 2031
 Figure 4. Capsule Product Picture
 Figure 5. Suspension Product Picture
 Figure 6. Global Oseltamivir Phosphate Antiviral Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Oseltamivir Phosphate Antiviral Drug Market Share by Application: 2024 & 2031
 Figure 8. Child
 Figure 9. Aldult
 Figure 10. Global Oseltamivir Phosphate Antiviral Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Oseltamivir Phosphate Antiviral Drug Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Oseltamivir Phosphate Antiviral Drug Sales (2020-2031) & (K Units)
 Figure 13. Global Oseltamivir Phosphate Antiviral Drug Average Price (US$/Unit) & (2020-2031)
 Figure 14. Oseltamivir Phosphate Antiviral Drug Report Years Considered
 Figure 15. Oseltamivir Phosphate Antiviral Drug Sales Share by Manufacturers in 2024
 Figure 16. Global Oseltamivir Phosphate Antiviral Drug Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Oseltamivir Phosphate Antiviral Drug Players: Market Share by Revenue in Oseltamivir Phosphate Antiviral Drug in 2024
 Figure 18. Oseltamivir Phosphate Antiviral Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Oseltamivir Phosphate Antiviral Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Oseltamivir Phosphate Antiviral Drug Sales Market Share by Country (2020-2031)
 Figure 21. North America Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Country (2020-2031)
 Figure 22. United States Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Oseltamivir Phosphate Antiviral Drug Sales Market Share by Country (2020-2031)
 Figure 25. Europe Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Oseltamivir Phosphate Antiviral Drug Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Region (2020-2031)
 Figure 33. China Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Oseltamivir Phosphate Antiviral Drug Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Oseltamivir Phosphate Antiviral Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Oseltamivir Phosphate Antiviral Drug by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Oseltamivir Phosphate Antiviral Drug by Type (2020-2031)
 Figure 52. Global Oseltamivir Phosphate Antiviral Drug Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Oseltamivir Phosphate Antiviral Drug by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Oseltamivir Phosphate Antiviral Drug by Application (2020-2031)
 Figure 55. Global Oseltamivir Phosphate Antiviral Drug Price (US$/Unit) by Application (2020-2031)
 Figure 56. Oseltamivir Phosphate Antiviral Drug Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona